Medtronic Displays Patient Monitoring Systems at MEDICA 2019
By HospiMedica International staff writers Posted on 21 Nov 2019 |

Image: Emprint ablation system with Thermosphere technology (Photo courtesy of Medtronic plc)
Medtronic plc (Fridley, MN, USA) displayed its patient monitoring systems at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA 2019 which drew 120,000 trade visitors from over 170 countries.
Medtronic is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. At MEDICA 2019, Medtronic displayed its patient monitoring systems, including the Emprint SX ablation platform with Thermosphere technology, a cutting-edge, integrated surgical navigation and ablation platform that reduces procedural complexity and improves the targeting accuracy of soft tissue ablation. The Emprint SX’s navigation software improves successful antenna placement versus standard ultrasound guidance upon first attempt. Its advanced 3-D tracking shows the position of the Emprint SX ablation antenna and ultrasound transducer relative to the surgeon’s perspective in real-time.
Medtronic also displayed the Emprint ablation system with Thermosphere technology that can be used for ablation in other soft tissue within the body. The Thermosphere technology provides clinicians with three kinds of spatial energy control — thermal, field and wavelength. This maintains a predictable, spherical ablation zone throughout a procedure, and brings new confidence to the ablation of liver tumors.
Among other patient monitoring systems displayed by Medtronic at this year’s MEDICA was the Cardioblate 68000 generator which is easy to set up and use. Its advanced dose-response algorithm customizes energy delivery based on tissue impedance to achieve reliable, reproducible transmurality, ensuring transmural lesions that consistently result in conduction block. It features touch screen operation for adjusting ablation parameters, while audible tones and touch screen messages notify user of ablation status, transmurality, and other critical information.
Related Links:
Medtronic plc
Medtronic is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. At MEDICA 2019, Medtronic displayed its patient monitoring systems, including the Emprint SX ablation platform with Thermosphere technology, a cutting-edge, integrated surgical navigation and ablation platform that reduces procedural complexity and improves the targeting accuracy of soft tissue ablation. The Emprint SX’s navigation software improves successful antenna placement versus standard ultrasound guidance upon first attempt. Its advanced 3-D tracking shows the position of the Emprint SX ablation antenna and ultrasound transducer relative to the surgeon’s perspective in real-time.
Medtronic also displayed the Emprint ablation system with Thermosphere technology that can be used for ablation in other soft tissue within the body. The Thermosphere technology provides clinicians with three kinds of spatial energy control — thermal, field and wavelength. This maintains a predictable, spherical ablation zone throughout a procedure, and brings new confidence to the ablation of liver tumors.
Among other patient monitoring systems displayed by Medtronic at this year’s MEDICA was the Cardioblate 68000 generator which is easy to set up and use. Its advanced dose-response algorithm customizes energy delivery based on tissue impedance to achieve reliable, reproducible transmurality, ensuring transmural lesions that consistently result in conduction block. It features touch screen operation for adjusting ablation parameters, while audible tones and touch screen messages notify user of ablation status, transmurality, and other critical information.
Related Links:
Medtronic plc
Latest Medica 2019 News
- Varex Highlights Advanced Imaging Components at MEDICA 2019
- Samsung Medison Exhibits New HERA I10 Combination Ultrasound System
- Healcerion Exhibits SONON Wireless Handheld Ultrasound at MEDICA 2019
- Hans Rudolph Exhibits Latest Range of Oro-Nasal Masks at MEDICA 2019
- EIZO Demonstrates CuratOR Alipe IP-Based Video Management Solution at MEDICA 2019
- Intersurgical Exhibits Full Range of Respiratory Products at MEDICA 2019
- GINEVRI Showcases Neonatal Incubators and Warmers at MEDICA 2019
- Rober Launches New Pediatric Pressure Care Mattress at MEDICA 2019
- DuPont Introduces Next Generation of Wireless Wearable Monitoring Solutions
- Aerotel Medical Systems Showcases Full Range of RPM and Professional ECG Recorders
- Sony Unveils Latest End-to-End 4K3D/4K Surgical Imaging Solutions and Technologies
- Merivaara Showcases New Operating Room Innovations at MEDICA 2019
- DTR Medical Exhibits Range of Sterile Single-Use Instruments at MEDICA 2019
- MAVIG GmbH Showcases X-Ray Protective Clothing and Suspension Systems for Medical Equipment
- Huntleigh Healthcare Showcases Obstetrics Products and Software Systems at MEDICA 2019
- KUKA AG Presents First Collaborative Robot for Medical Sector at MEDICA 2019
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreCritical Care
view channel
Novel Coating Significantly Extends Longevity of Implantable Biosensors
Wearable and implantable biosensors capable of accurately detecting biological molecules in a non-invasive or minimally invasive way offer enormous potential for monitoring patients’ health and their responses... Read more
Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
Urinary tract infections (UTIs) are not only widespread and costly but also highly debilitating, significantly impacting the quality of life for those affected. The antibiotics commonly used to treat UTIs... Read more
New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
Preventable medication errors affect around 500,000 hospitalized patients in the U.S. every year. A significant portion of these errors occur with intravenous (IV) smart pumps, which require a precise... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more